IMO I believe that is unlikely, the transaction cost associated with vertically integrating a domestic company is going to be less than building that tech from scratch (tritium must have identified some value in RFT to partner with them in the first place). I'm sure they'd prefer to keep their existing product consistent with future products, especially from a servicability and reputation perspective as well (at least I hope!).
Any insight into why my logic might be wrong would be appreciated.
- Forums
- ASX - By Stock
- RFT
- Tritium wins big UK electric vehicle charging deal - AFR
Tritium wins big UK electric vehicle charging deal - AFR, page-20
Featured News
Add RFT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.43M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 0.9¢ | $9.995K | 995K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1533996 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 8283849 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1533996 | 0.009 |
7 | 896000 | 0.008 |
9 | 1332529 | 0.007 |
5 | 1984501 | 0.006 |
3 | 482000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 8283849 | 2 |
0.011 | 4832805 | 1 |
0.012 | 3284620 | 7 |
0.013 | 1155500 | 3 |
0.014 | 70000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RFT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online